预测检查点抑制剂相关的自身免疫糖尿病:前景和局限性
Kevan C Herold1,2, Ana Luisa Perdigoto1,3
1Department of Internal Medicine, and.
The Journal of clinical investigation
|February 16, 2026
概括
检查点抑制剂相关的自身免疫糖尿病 (CIADM) 是癌症免疫疗法的严重副作用. 治疗前的因素,如胰腺体量减少和免疫生物标志物,预测CIADM的发展,有助于患者监测和预防.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 免疫检查点抑制剂 (ICI) 是关键的癌症疗法.
- 检查点抑制剂相关的自身免疫糖尿病 (CIADM) 是ICI治疗的严重并发症.
- 对于CIADM的预测因素在很大程度上仍未确定.
研究的目的:
- 在接受ICI治疗的癌症患者中确定治疗前的CIADM风险因素和预测因素.
主要方法:
- 对血清和外周血液单核细胞 (PBMC) 的分析.
- 14名ICI治疗的CIADM患者和28名没有CIADM的对照患者之间的比较.
主要成果:
- 在ICI治疗前,在CIADM患者中观察到胰腺体体积减少.
- 岛屿自身抗体和免疫细胞激活生物标志物的存在预测了CIADM.
- 这些因素的结合证明了CIADM开发的高预测价值.
结论:
- 治疗前的变量包括胰腺体积,自身抗体和免疫细胞激活标志物可以预测CIADM.
- 这些发现对临床决策,患者监测和CIADM潜在的预防策略有重大影响.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Dipeptidyl Peptidase 4 Inhibitors
729
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
729
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K


